Email ID
Sign me in automatically next time
ImmusanT start-up raises $20m to advance therapeutic vaccine for coeliac disease

ImmusanT, a US biotech which was launched in March 2011 from research which originated in Australia, has raised $20 million in a series A round of financing from Vatera Healthcare Partners...
15 December 2011
Nancy Faigen

Please Login to read the full article.
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36